Financials

  • Market Capitalization 15.37 M
  • Employee 18
  • Founded 2017
  • CEO N/A
  • Website vyometx.com
  • Headquarter Delaware, United States
  • FIGI BBG0036S6JY0
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.71
Fiyat/satışlar oranı
23.26

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
4697
CYCN
Cyclerion Therapeutics, Inc. - Common Stock
3.71 USD-4.38%+9.76%+12.08%+14.15%16.07 M USD
4704
AKTX
Akari Therapeutics Plc - American Depositary Shares
13.61 USD+1.57%-8.60%+1.19%+1126.13%15.58 M USD
4711
QNCX
Quince Therapeutics, Inc. - Common Stock
18.73 USD+8.58%+12.63%+1913.98%+934.81%15.27 M USD
4722
LEXX
Lexaria Bioscience Corp. - Common Stock
0.59 USD0.00%+11.32%-1.67%-29.76%14.62 M USD